A new tumorgraft panel to accelerate precision medicine in prostate cancer

BACKGROUND: Despite the significant advances in the management of advanced prostate cancer (PCa), metastatic PCa is currently considered incurable. For further investigations in precision treatment, the development of preclinical models representing the complex prostate tumor heterogeneity are manda...

Descripción completa

Detalles Bibliográficos
Autores principales: Béraud, Claire, Bidan, Nadege, Lassalle, Myriam, Lang, Hervé, Lindner, Véronique, Krucker, Clémentine, Masliah-Planchon, Julien, Potiron, Eric, Lluel, Philippe, Massfelder, Thierry, Allory, Yves, Misseri, Yolande
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250751/
https://www.ncbi.nlm.nih.gov/pubmed/37305585
http://dx.doi.org/10.3389/fonc.2023.1130048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250751/
https://www.ncbi.nlm.nih.gov/pubmed/37305585
http://dx.doi.org/10.3389/fonc.2023.1130048

Ejemplares similares